Background: Positron emission tomography (PET) imaging with 68Gallium labeled somatostatin analogues (68Ga-DOTA-SSA) plays a key role in neuroendocrine tumor management. The impact of patient size on PET image quality is not well known for PET imaging with 68Ga-DOTA-SSA. The aim of this study is to propose a dose regimen based on patient size that optimizes image quality and yields sufficient image quality for diagnosis. Methods: Twenty-one patients (12 males, 9 females) were prospectively included for 68Gallium-DOTA-Tyr3-Octreotate (68Ga-DOTA-TATE) PET/CT, which was acquired in whole body list mode using 6 min per bed position (mbp). The list-mode events were randomly sampled to obtain 1 to 6 mbp PET reconstructions. For semi-quantitative ...
68Ga-DOTA-SSTRTs PET/CT has become the most promising noninvasive procedure to study well-differenti...
Purpose: Clinically non-functioning pituitary macroadenomas (NFMA) have been reported to express som...
International audience68Ga-DOTA-DPhe1,Tyr3-octreotate (68Ga-DOTATATE) is a somatostatin analogue tha...
PURPOSE Radiolabelled somatostatin analogues targeting somatostatin receptors (SSR) are well establi...
Somatostatin receptor PET tracers such as [68Ga-DOTA,1-Nal3]-octreotide (68Ga-DOTANOC) and [68Ga-DOT...
Abstract Background The injection activity of tracer, acquisition time, patient-specific photon atte...
Purpose A high SUVmax tumor-to-liver ratio (TLR) of 68Ga-DOTATATE can be used to select patients wit...
Objectives: Somatostatin is an endocrine peptide hormone that regulates neurotransmission and cell p...
Objectives: To assess how patients' dependent parameters may affect [68Ga]Ga-DOTANOC image quality a...
Background: Somatostatin receptor 68Ga PET imaging is standard for evaluation of a patient’s suitabi...
Neuroendocrine tumors (NETs) are characterized by cellular overexpression of somatostatin receptors ...
Somatostatin (SMS) scintigraphy is widely used for the detection and staging of neuroendocrine tumou...
Contains fulltext : 89608.pdf (publisher's version ) (Closed access)The aim of the...
AimTo assess the additional contribution of the combined imaging approach with Ga-68-DOTA-TATE and f...
Rationale:In the diagnostics of neuroendocrine tumors (NETs), scintigraphy and Single Photon Emissio...
68Ga-DOTA-SSTRTs PET/CT has become the most promising noninvasive procedure to study well-differenti...
Purpose: Clinically non-functioning pituitary macroadenomas (NFMA) have been reported to express som...
International audience68Ga-DOTA-DPhe1,Tyr3-octreotate (68Ga-DOTATATE) is a somatostatin analogue tha...
PURPOSE Radiolabelled somatostatin analogues targeting somatostatin receptors (SSR) are well establi...
Somatostatin receptor PET tracers such as [68Ga-DOTA,1-Nal3]-octreotide (68Ga-DOTANOC) and [68Ga-DOT...
Abstract Background The injection activity of tracer, acquisition time, patient-specific photon atte...
Purpose A high SUVmax tumor-to-liver ratio (TLR) of 68Ga-DOTATATE can be used to select patients wit...
Objectives: Somatostatin is an endocrine peptide hormone that regulates neurotransmission and cell p...
Objectives: To assess how patients' dependent parameters may affect [68Ga]Ga-DOTANOC image quality a...
Background: Somatostatin receptor 68Ga PET imaging is standard for evaluation of a patient’s suitabi...
Neuroendocrine tumors (NETs) are characterized by cellular overexpression of somatostatin receptors ...
Somatostatin (SMS) scintigraphy is widely used for the detection and staging of neuroendocrine tumou...
Contains fulltext : 89608.pdf (publisher's version ) (Closed access)The aim of the...
AimTo assess the additional contribution of the combined imaging approach with Ga-68-DOTA-TATE and f...
Rationale:In the diagnostics of neuroendocrine tumors (NETs), scintigraphy and Single Photon Emissio...
68Ga-DOTA-SSTRTs PET/CT has become the most promising noninvasive procedure to study well-differenti...
Purpose: Clinically non-functioning pituitary macroadenomas (NFMA) have been reported to express som...
International audience68Ga-DOTA-DPhe1,Tyr3-octreotate (68Ga-DOTATATE) is a somatostatin analogue tha...